ESC Premium Access

Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolaemia: the Trial Assessing long-term Use of PCSK9 inhibition in Subjects with Genetic LDL disorders (TAUSSIG)

Congress Presentation

About the speaker

Professor Frederick Raal

University of the Witwatersrand, Johannesburg (South Africa)
1 presentation
0 follower

8 more presentations in this session

Risk of incident atherosclerotic cardiovascular disease events by atherogenic lipid levels in a real-world population of 62,428 on-statin individuals with diabetes

Speaker: Assistant Professor J. Rana (Oakland, US)


Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease using clinical trial evidence: results from the prospective population-based Rotterdam Study

Speaker: Doctor M. Leening (Rotterdam, NL)


Effects of morning versus evening statin therapy on lipid profile: A systematic review and meta-analysis

Speaker: Doctor P. Penson (Liverpool, GB)


Familial hypercholesterolemia: development of a next generation sequencing approach to the disease

Speaker: Associate Professor R. Marcucci (Florence, IT)


Comprehensive genotyping and phenotyping in patients with severe hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)


Access the full session

Lipid lowering therapy in primary cardiovascular prevention

Speakers: Professor F. Raal, Assistant Professor J. Rana, Doctor M. Leening, Doctor P. Penson, Associate Professor R. Marcucci...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb